Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALNY
#447
Alnylam Pharmaceuticals, Inc. - Common Stock
223.8
2
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.41%
Monthly Change
-9.38%
6 month change
-34.56%
Year Change
-52.30%
Previous Close
227.0
2
Open
228.9
3
Low
221.5
6
High
229.5
3
Markets
US Stock Market
Healthcare
Biotechnology
ALNY
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
117 M
120.21 M
124.13 M
125.95 M
129.46 M
132.62 M
133.81 M
Valuation ratios
Enterprise value
14.9 B
20.24 B
29.15 B
24.76 B
30.52 B
52.09 B
28.7 B
Price to earnings ratio
—
-23.55
-25.12
-55.38
-107.94
170.67
40.91
Price to sales ratio
—
23.79
27.4
13.32
13.36
14.42
6.27
Price to cash flow ratio
—
-31.3
-52.52
233.76
-3 613.76
102.19
40.16
Price to book ratio
—
34.15
-179.65
-110.35
447.73
67.86
8.74
Enterprise value to EBITDA ratio
-18.67
-30.13
-39.07
-107.38
-250.61
93.62
—
Profitability ratios
Return on assets %
-0.25
-0.23
-0.32
-0.11
-0.07
0.06
0.03
Return on equity %
-0.84
-1.45
7.15
2
-4.15
0.4
0.12
Return on invested capital %
-345.98
-259.06
-306.69
-109.75
-47.38
164.23
70.38
Gross margin %
84.16
86.38
86.49
85.33
86.37
81.77
76.9
Operating margin %
-168.09
-83.93
-75.68
-15.43
-7.87
13.51
17.93
EBITDA margin %
-161.96
-79.58
-71.91
-12.61
-5.42
14.98
—
Net margin %
-174.15
-101.01
-109.04
-24.08
-12.37
8.45
12.74
Liquidity ratios
Quick ratio
4.34
3.91
3.34
2.99
2.71
2.71
2.99
Current ratio
4.47
4.04
3.51
3.08
2.78
2.76
3.05
Inventory turnover
1.19
1.42
1.3
2.46
3.66
8.19
3.29
Asset turnover
0.17
0.24
0.29
0.5
0.56
0.75
0.24
Solvency ratios
Debt to assets ratio
0.06
0.19
0.29
0.27
0.24
0.2
0.18
Debt to equity ratio
0.19
1.15
-6.43
-4.63
15.27
1.28
0.75
Long term debt to total assets ratio
0.06
0.19
0.29
0.27
0.24
0.2
0.18
Long term debt to total equity ratio
0.19
1.15
-6.43
-4.63
15.27
1.28
0.75
Per share metrics
Operating cash flow per share
—
-5.42
-4.45
0.83
-0.07
3.89
5.47
EBIT per share
—
-5.98
-6.45
-2.26
-1.39
3.72
7.27
EBITDA per share
—
-5.67
-6.13
-1.85
-0.95
4.13
—
Total debt per share
—
5.7
8.36
8.17
8.03
7.48
7.31
Cash per share
—
20.56
18.02
19.53
21.11
21.59
23.92
Net current asset value per share
—
23.71
22.12
23.88
25.81
30.08
33.41
Tangible book value per share
—
4.97
-1.3
-1.77
0.53
5.86
9.79
Working capital per share
—
17.84
15.81
16.13
16.52
19.19
22.47
Book value per share
—
4.97
-1.3
-1.77
0.53
5.86
9.79
News
If You Invested $1000 In Alnylam Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today
Stocks Finish Lower Ahead of Wednesday’s CPI Report
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
Viatris to Buy Pacira for $1.65B to Expand Non-Opioid Pain Portfolio
ARGX Stock Down on Stopping Late-Stage Autoimmune Disease Study
RBC Capital Maintains Outperform on Alnylam Pharmaceuticals, Lowers Price Target to $345
Here's Why You Should Add LPCN Stock to Your Portfolio Now
Ultragenyx to Sell Rare Pediatric Disease PRV for $210M to Boost Cash
Stocks Fall and Bond Yields Rise on Inflation Worries
ETON Stock Surges 108% in Six Months: Here's What You Need to Know
Stocks Pressured by Rising Bond Yields